Tessera Therapeutics
Ada Del Cid is a Senior Engineer I at Tessera Therapeutics, where responsibilities include leading the development of high throughput processes for lipid nanoparticle formulations and coordinating the installation of new instruments. Previous roles include serving as a Build Fellow at Open Avenues, focusing on education for underrepresented student populations, and acting as Secretary for the SHPE Georgia Professional Chapter. Ada has experience as a Research Technician II at Georgia Institute of Technology, where significant contributions included implementing Python code for sequencing data analysis and developing RNA-based pharmaceuticals. Educational credentials include a Master's of Science in Biomedical Engineering from Georgia Institute of Technology and a B.S. in Chemical-Biomedical Engineering from Florida State University.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.